Progyny Rises Again as Wall Street Keeps Buying Fertility-Benefits Rebound
Progyny Inc. shares rose Thursday morning, stretching a rebound as investors responded to analyst backing and steady member demand at the fertility-benefits provider. The stock gained 84 cents, or roughly 3.4%, to $25.83 as of 10:45 a.m. EDT. Shares changed hands between $25.01 and $25.87 earlier. The company had a market cap of about $2.19 billion.